David Liu (Broad Institute)
September 20, 2022 03:26 PM EDTUpdated September 23, 02:35 AM
Discovery
Cell/Gene Tx

New patent on the prime edit­ing of DNA award­ed to Broad In­sti­tute's David Liu

Zachary Brennan

Senior Editor

The genome edit­ing rev­o­lu­tion will be patent­ed. Or at least that’s the case for this lat­est US patent, award­ed Tues­day to the Broad In­sti­tute’s David …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

A service from the Financial Times